Drug industry and KFDA disputed on DMF postponement.

Published: 2005-07-29 06:59:00

Updated: 2005-07-29 06:59:00

The DMF (data master file) system in the bulk drug report program was scheduled to implement from coming Sept. 1, but the Korea Pharmaceutical Cooperative Association proposed to the KFDA for a probation period on account of its difficulties prior to its enforcement, for which the KFDA made it cl...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK